Granulocyte-Macrophage Colony Stimulatory Factor Enhances the Pro-Inflammatory Response of Interferon-γ-Treated Macrophages to Pseudomonas aeruginosa Infection

被引:14
|
作者
Singh, Sonali
Barr, Helen
Liu, Yi-Chia
Robins, Adrian
Heeb, Stephan
Williams, Paul
Fogarty, Andrew
Camara, Miguel
Martinez-Pomares, Luisa
机构
[1] School of Life Sciences, University of Nottingham, Nottingham
[2] School of Medicine, University of Nottingham, Nottingham
[3] School of Community Health Sciences, University of Nottingham, Nottingham
来源
PLOS ONE | 2015年 / 10卷 / 02期
关键词
CYSTIC-FIBROSIS PATIENTS; GM-CSF; SUPPRESSOR-CELLS; LUNG INFECTION; T-CELLS; ALTERNATIVE ACTIVATION; CYTOKINE PROFILE; IMMUNE-RESPONSE; HOST RESPONSE; PHAGOCYTOSIS;
D O I
10.1371/journal.pone.0117447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections at compromised epithelial surfaces, such those found in burns, wounds, and in lungs damaged by mechanical ventilation or recurrent infections, particularly in cystic fibrosis (CF) patients. CF patients have been proposed to have a Th2 and Th17-biased immune response suggesting that the lack of Th1 and/ or over exuberant Th17 responses could contribute to the establishment of chronic P. aeruginosa infection and deterioration of lung function. Accordingly, we have observed that interferon (IFN)-gamma production by peripheral blood mononuclear cells from CF patients positively correlated with lung function, particularly in patients chronically infected with P. aeruginosa. In contrast, IL-17A levels tended to correlate negatively with lung function with this trend becoming significant in patients chronically infected with P. aeruginosa. These results are in agreement with IFN-gamma and IL-17A playing protective and detrimental roles, respectively, in CF. In order to explore the protective effect of IFN-gamma in CF, the effect of IFN-gamma alone or in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), on the ability of human macrophages to control P. aeruginosa growth, resist the cytotoxicity induced by this bacterium or promote inflammation was investigated. Treatment of macrophages with IFN-gamma, in the presence and absence of GM-CSF, failed to alter bacterial growth or macrophage survival upon P. aeruginosa infection, but changed the inflammatory potential of macrophages. IFN-gamma caused up-regulation of monocyte chemoattractant protein-1 (MCP-1) and TNF-alpha and down-regulation of IL-10 expression by infected macrophages. GM-CSF in combination with IFN-gamma promoted IL-6 production and further reduction of IL-10 synthesis. Comparison of TNF-alpha vs. IL-10 and IL-6 vs. IL-10 ratios revealed the following hierarchy in regard to the pro-inflammatory potential of human macrophages infected with P. aeruginosa: untreated < treated with GM-CSF < treated with IFN-gamma < treated with GM-CSF and IFN-gamma.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines
    Zaheer, Asgar
    Zaheer, Smita
    Sahu, Shailendra K.
    Knight, Scott
    Khosravi, Houdy
    Mathur, Satya N.
    Lim, Ramon
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (02) : 364 - 376
  • [2] Interferon-γ and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis
    Bandera, A.
    Trabattoni, D.
    Ferrario, G.
    Cesari, M.
    Franzetti, F.
    Clerici, M.
    Gori, A.
    INFECTION, 2008, 36 (04) : 368 - 373
  • [3] Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis
    A. Bandera
    D. Trabattoni
    G. Ferrario
    M. Cesari
    F. Franzetti
    M. Clerici
    A. Gori
    Infection, 2008, 36 : 368 - 373
  • [4] Interferon-γ enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5
    Yamaguchi, Takafumi
    Kimura, Hirokazu
    Kurabayashi, Masahiko
    Kozawa, Kunihisa
    Kato, Masahiko
    IMMUNOLOGY LETTERS, 2008, 118 (01) : 88 - 95
  • [5] Granulocyte-macrophage colony-stimulating-factor increases interferon-τ protein secretion in bovine trophectoderm cells
    Michael, Donna D.
    Wagner, Sara K.
    Ocon, Olga M.
    Talbot, Neil C.
    Rooke, John A.
    Ealy, Alan D.
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2006, 56 (01) : 63 - 67
  • [6] Beyond immunochemotherapy:: Combinations of rituximab with cytokines interferon-α2a and granulocyte-macrophage colony stimulating factor
    Kimby, E
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 7 - 10
  • [7] PROTECTIVE EFFECT OF RECOMBINANT MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AGAINST PSEUDOMONAS-AERUGINOSA INFECTION IN LEUKOCYTOPENIC MICE
    TANAKA, T
    OKAMURA, S
    OKADA, K
    SUGA, A
    SHIMONO, N
    OHHARA, N
    HIROTA, Y
    SAWAE, Y
    NIHO, Y
    INFECTION AND IMMUNITY, 1989, 57 (06) : 1792 - 1799
  • [8] DIFFERENTIAL REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE-EXPRESSION IN HUMAN CORNEAL CELLS BY PRO-INFLAMMATORY CYTOKINES
    CUBITT, CL
    LAUSCH, RN
    OAKES, JE
    JOURNAL OF IMMUNOLOGY, 1994, 153 (01): : 232 - 240
  • [9] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ENHANCES EXUDATION OF NEUTROPHILS TO SITES OF INFLAMMATORY CHALLENGE INVIVO
    MOCK, BH
    ENGLISH, D
    JOURNAL OF LIPID MEDIATORS, 1990, 2 : S137 - S141
  • [10] Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma
    John, M
    Lim, S
    Seybold, J
    Jose, P
    Robichaud, A
    O'Connor, B
    Barnes, PJ
    Chung, KF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) : 256 - 262